AusPAR: Sofosbuvir/velpatasvir

Australian Public Assessment Report

AusPAR

AusPAR: Sofosbuvir/velpatasvir [PDF, 389.76 KB]

AusPAR: Sofosbuvir/velpatasvir [Word, 132.11 KB]

Attachment: Product Information for Sofosbuvir/velpatasvir [PDF, 441.51 KB]

Attachment: Product Information for Sofosbuvir/velpatasvir [Word, 159.04 KB]

Device/Product Name

Epclusa

Active ingredients

Sofosbuvir/velpatasvir

AusPAR Date

26 August 2021

Published

21 September 2021

Submission Number

PM 2020-00171-1-2

Submission Type

Extension of indications

Decision

Approved